CCND1 and nasopharyngeal carcinoma: The AUC for cyclin D1 expression in the prediction of NPC patients was 0.752 (95% confidence interval = 0.705‐0.798, P < .001), with a sensitivity of 53.6%, and specificity of 85.7%.